HYBRID EVENT: You can participate in person at Valencia, Spain or Virtually from your home or work.

4th Edition of Cardiology World Conference

September 18-20, 2022 | Hybrid Event

September 18 -20, 2023 | Valencia, Spain

Cardio 2023

Dhulipalla Dharma Teja, Speaker at Cardiology Conferences
Oral Presentation (In-Person)
Dhulipalla Dharma Teja, MBBS, MD, DM Cardiology, India

Introduction: Cancer therapy-related cardiac dysfunction (CTRCD) is one of the side effects experienced by nearly one-tenth of cancer survivors. LVEF and GLS have been proposed as a marker to predict CTRCD. Recent studies also suggest assessment of cardiac biomarkers including tr [....] » Read More

Hedva Haykin, Speaker at Cardiology Conference
Oral Presentation (In-Person)
Hedva Haykin, Technion- Institute of Technology, Israel

Background:  Epidemiological data show a correlation between negative emotional states, such as depression and stress, to a higher incidence of acute cardiovascular events like myocardial infarction (MI), with more frequently occurring comorbidities and mortality. Consistent [....] » Read More

Ahmed Ibrahim Hatata , Speaker at Cardiovascular Conference
Oral Presentation (In-Person)
Ahmed Ibrahim Hatata , Ain Shams University , Egypt

The adenosine is an available drug  and the tool is ready for treatment of no reflow but how is the drug is used in prevention of no reflow was the study. In this study we used adenosine as primary intervention for no reflow after establishing TIMI I flow in primary PCI [....] » Read More

Yeganeh Mobasser, Speaker at Cardiology Conferences
Oral Presentation (In-Person)
Yeganeh Mobasser, MUMS, Iran (Islamic Republic of)

Despite evidence showing the effect of vasoactive hormones including aldosterone in pulmonary arterial hypertension (PAH) pathophysiology, few clinical reports are available concerning the effect of PAH treatment with aldosterone antagonists. Therefore, in this study, we evaluate [....] » Read More

Nahid Mobasser, Speaker at Cardiovascular Diseases Events
Oral Presentation (In-Person)
Nahid Mobasser, ZUMS, Iran (Islamic Republic of)

Purpose: The purpose of this study was to investigate the effect of exercise training on exercise tolerance and left ventricular diastolic function and structure in patients with chronic cardiac ischemia. Methods: Eighty-eight patients with cardiac ischemia and diastolic disfu [....] » Read More

William Bernard Ong, Speaker at Cardiovascular Conference
Oral Presentation (In-Person)
William Bernard Ong, St. Luke’s Medical Center, Philippines

Background: Venous thromboembolism (VTE) causes significant morbidity and mortality among cancer patients. Use of low molecular weight heparin is the recommended therapeutic regimen in the prevention of VTE, however it has numerous disadvantages including discomfort, cost, safe [....] » Read More

Linda Shirindi, Speaker at Cardiology Conference
Oral Presentation (In-Person)
Linda Shirindi, University of South Africa, South Africa

Stakeholder collaboration is significant to the contribution and improvement of psycho-social functioning and resilience of women living with hypertension. The purpose of the study was to explore and describe perceptions of stakeholders in addressing psycho-social needs of women [....] » Read More

Nightingale Syabbalo, Speaker at Cardiology Conference
Oral Presentation (In-Person)
Nightingale Syabbalo, Nabanji Medical Center, Zambia

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID-19) is caused by an enveloped, single-stranded RNA betacoronavirus belonging to the corona viridae 2B lineage. Several epidemics of SARS-CoV-2 due to different variants have caused severe morbidities and deaths in [....] » Read More

Kevin Paul Enriquez, Speaker at Cardiology Conferences
Oral Presentation (In-Person)
Kevin Paul Enriquez, Philippine General Hospital, Philippines

Chylopericardium is a rare condition in which there is accumulation of chylous fluid in the pericardial cavity. Commonly it is idiopathic, postoperative, or neoplastic. Tuberculosis (TB) as a cause has infrequently been reported. Optimal management is unclear, being conservative [....] » Read More

Kevin Paul Enriquez, Speaker at Cardiology Conferences
Oral Presentation (In-Person)
Kevin Paul Enriquez, Philippine General Hospital, Philippines

Chylopericardium is a rare condition in which there is accumulation of chylous fluid in the pericardial cavity. Commonly it is idiopathic, postoperative, or neoplastic. Tuberculosis (TB) as a cause has infrequently been reported. Optimal management is unclear, being conservative [....] » Read More

Indrajeet Mahata, Speaker at Cardiology Conferences
Poster Presentation (In-Person)
Indrajeet Mahata, University of Missouri, United States

Introduction: The accurate diagnosis and initial evaluation of Wide complex tachycardia (WCT) has been a traditional clinical dilemma. The differential diagnosis includes ventricular tachycardia (VT), supraventricular tachycardia (SVT with aberration and SVT with pre-excitat [....] » Read More

Ishan Verma, Speaker at Cardiovascular Diseases Events
Poster Presentation (In-Person)
Ishan Verma, AIIMS Nagpur, India

A 21 year old female was brought to the emergency department of our hospital with alleged history of celphos consumption an hour back at home. Following consumption, she had 2 episodes of vomiting. On arrival in the emergency, she was irritable and in gasping condition. Endotrach [....] » Read More

Laila Rejali, Speaker at Cardiovascular Diseases Events
Poster Presentation (In-Person)
Laila Rejali, Islamic Azad University, Iran (Islamic Republic of)

Background: SARS-CoV-2 entry requires cleavage of the spike glycoprotein at the S1/S2 and the S2? cleavage sites to mediate membrane fusion. The furin cleavage site is an important determinant of SARS-CoV-2 transmission. Through proteolytic cleavage of ADAM17, furin also indirect [....] » Read More

Aisha Oluwabunmi Ajala, Speaker at Cardiology Conference
Poster Presentation (In-Person)
Aisha Oluwabunmi Ajala, University of port-harcourt teaching hospital, Nigeria

Background Cardiovascular disease (CVD) accounts for the major cause of morbidity and mortality in older adults and occurs amidst several co-morbidities and geriatric syndromes. Nigeria, with the largest growing economy in the continent is not spared by the process of aging of [....] » Read More

Kate Tauber, Speaker at Cardiology Conference
Oral Presentation (Virtual)
Kate Tauber, Albany Medical Center, United States

Congenital heart disease is one of the more common congenital anomalies with an incidence of approximately 4 per 1000 live births.  Although many of these infants are born at term with birthweights well within the normal range, they often can develop growth failure due to in [....] » Read More

Billy Joseph David, Speaker at Cardiology Conferences
Oral Presentation (Virtual)
Billy Joseph David, St. Luke’s Medical Center, Philippines

Introduction: Exercise intolerance in patients with heart failure leads to a lower quality of life. An increasing number of studies suggest that early initiation of guided-directed medical therapy (GDMT) leads to better outcomes. Sodium-glucose co-transporter-2 (SG [....] » Read More

Ana Faustino, Speaker at Cardiology Conference
Oral Presentation (Virtual)
Ana Faustino, University of Évora, Portugal

Animals are an important tool for studying human diseases. Our research team has used rodents as models of metabolic and oncological diseases, like diabetes and prostate, mammary, colon, liver, and urinary bladder cancers. In our experiments, we have monitored the cardiac funct [....] » Read More

Barbara, Speaker at Cardiology Conference
Oral Presentation (Virtual)
Barbara, Sapienza Università di Roma, Italy

Cardiovascular disease is the leading cause of mortality for women and is responsible for 35% of total deaths in women, since there is a growing interest (as the Lancet Commission alert) on reducing the global burden of cardiovascular disease. It is estimated that obesity contrib [....] » Read More

Jun  Wu, Speaker at Cardiovascular Conference
Oral Presentation (Virtual)
Jun Wu, The Second Affiliated Hospital of Dalian Medical University, China

Background Aortic regurgitation changes the loading condition of the aorta, and the changes of the longitudinal strain of the sinus of Valsalva and the  ascending aorta remains unclear.The purpose of this study was to evaluate the longitudinal strain of the sinus of Valsalva [....] » Read More

Linfeng Xie, Speaker at Cardiovascular Diseases Events
Oral Presentation (Virtual)
Linfeng Xie, Jian Medical University Union Hospital, China

Background: There are few reports of total arch replacement through a partial upper sternotomy in obese patients with type A aortic dissection, and the safety and feasibility of this procedure still need to be further investigated. The present study also sought to investigat [....] » Read More

Neelesh Kumar S Shah , Speaker at Cardiology Conferences
Oral Presentation (Virtual)
Neelesh Kumar S Shah , Consultant Interventional Cardiologist, India

Objective: To compare the levels of microRNA (miRNA) 24 levels in diabetic patients with acute coronary syndrome (ACS) with non-diabetics suffering from ACS. Methodology: A prospective case-control study was carried out among 40 patients with ACS residing in Belagavi, Karnatak [....] » Read More

Marina Awad Zaher, Speaker at Cardiovascular Diseases Events
Oral Presentation (Virtual)
Marina Awad Zaher, Beni-Suef University, Egypt

Background: Much concern was directed towards studying cardiovascular dysfunction in patients with multiple sclerosis (MS). However, the mechanisms of such dysfunction are not completely elucidated. Aim of the work: The aim of our work was to assess cardiac and arterial function [....] » Read More

Bijay Patni, Speaker at Cardiology Conference
Oral Presentation (Virtual)
Bijay Patni, Diabetes Wellness Care, India

Background & Objective The prevalence rate of Hyperuricemia is comparatively higher in Asian countries than in the western regions. Hypertensive patients with co-existing Hyperuricemia (HU) are at greater risk of uncontrolled HTN, metabolic syndrome and its complications. [....] » Read More

Bijay Patni, Speaker at Cardiology Conference
Oral Presentation (Virtual)
Bijay Patni, Diabetes Wellness Care, India

Background & Objective The prevalence rate of Hyperuricemia is comparatively higher in Asian countries than in the western regions. Hypertensive patients with co-existing Hyperuricemia (HU) are at greater risk of uncontrolled HTN, metabolic syndrome and its complications. [....] » Read More

 Asma Syed, Speaker at Cardiology Conference
Oral Presentation (Virtual)
Asma Syed, Brookdale Hospital Medical Center, United States

Risk factors for sudden cardiac death (SCD) and prevention guideline Incidence of SCD Review of SCD risk factors Risk factor reduction treatment Prevention guidelines Defibrillator (ICD) guidelines - USA

Jake Kieserman, Speaker at Cardiovascular Conference
Oral Presentation (Virtual)
Jake Kieserman, Hospital of the University of Pennsylvania, United States

Background:Myopericarditis is a rare complication of the mRNA Covid-19 vaccines, and often affects young males. We present a case of myopericarditis in a 68-year-old male with AML after receiving the 2nd booster (4th dose) of mRNA-1273 (Moderna booster). Case:A 68-year-old mal [....] » Read More

Ayan Ali, Speaker at Cardiology Conference
Oral Presentation (Virtual)
Ayan Ali, Hospital of the University of Pennsylvania, United States

Background:The clinical presentation of viral myocarditis is variable and is an important cause of cardiomyopathy worldwide. In some cases, symptoms are minimal consisting of mild fatigue and chest discomfort, where other cases result in fulminant heart failure, arrythmia and sud [....] » Read More

Swetha Kannan, Speaker at Cardiology Conferences
Oral Presentation (Virtual)
Swetha Kannan, Gulf Medical University, United Arab Emirates

The risk of cardiovascular disease increases at an alarming rate with the increase in an individual’s blood pressure. Rise in systemic arterial blood pressure can be caused by factors such as unhealthy diet (excessive intake of salts, trans-fats and saturated fats), alcohol [....] » Read More

Shubh Patel, Speaker at Cardiovascular Conference
Poster Presentation (Virtual)
Shubh Patel, University of Calgary, Canada

Background: Chest pain in patients with angina and no obstructive coronary artery disease (ANOCA) is a diagnostic and treatment challenge, resulting in a significant burden on healthcare resources. With increasing recognition of ANOCA, it is uncertain if the healthcare resource u [....] » Read More

 Malla Phanindra, Speaker at Cardiovascular Conference
Poster Presentation (Virtual)
Malla Phanindra, SCTIMST, India

Here I report a rare case of LAD mycotic Aneursym Post PCI which formed a Fistula to PA Audience Takeaway: Infective complications post PCI are rare. My presentation will help the clinicians to prevent future coronary complications I will present the complication of [....] » Read More

Sanya Ahmed, Speaker at Cardiology Conferences
Poster Presentation (Virtual)
Sanya Ahmed, SUNY Downstate College of Medicine, United States

  Purpose:High levels of coronary artery stenosis (>50%) increases the risk for ischemic heart disease, the leading cause of death worldwide. A novel procedure called intravascular lithotripsy (IVL) can reduce the levels of coronary artery stenosis by disrupting calc [....] » Read More

Sarmad Raza, Speaker at Cardiology Conferences
Poster Presentation (Virtual)
Sarmad Raza, Medical Teaching Institute, Pakistan

Objective: To know the clinical outcomes of percutaneous intervention (PCI) with drug eluting stents (DES) in patients with unprotected left main stem disease. Methodology & Theoretical Orientation: This single-center, prospective, observational study was conducted on 133 pat [....] » Read More

Yochai Birnbaum, Speaker at Cardiology Conferences
Keynote Presentation (Virtual)
Yochai Birnbaum, Baylor College of Medicine, United States

For years aspirin was considered an essential part of the treatment of patients with or at risk of coronary artery disease. However, more recent studies have shown that aspirin, even at low dose, does not improve outcomes when administered for primary prevention and is associated [....] » Read More

Will be updated soon......
Watsapp